Free Trial

Werewolf Therapeutics (HOWL) Insider Trading & Ownership

Werewolf Therapeutics logo
$1.33 -0.01 (-0.75%)
As of 01/17/2025 04:00 PM Eastern

Werewolf Therapeutics (NASDAQ:HOWL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
21.10%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$4.10 M
Number Of
Insiders Selling
(Last 3 Years)
0
Get HOWL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Werewolf Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HOWL Insider Buying and Selling by Quarter

Werewolf Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/6/2023Ra Capital Management, L.P.DirectorBuy1,853,000$2.21$4,095,130.00  
(Data available from 1/1/2013 forward)

HOWL Insider Trading Activity - Frequently Asked Questions

The list of insiders at Werewolf Therapeutics includes Ra Capital Management, L.P.. Learn more on insiders at HOWL.

21.10% of Werewolf Therapeutics stock is owned by insiders. Learn more on HOWL's insider holdings.

Werewolf Therapeutics Key Executives

  • Dr. Daniel J. Hicklin Ph.D. (Age 60)
    Founder, CEO, President, Secretary & Director
    Compensation: $928.26k
  • Mr. Timothy W. Trost CPA (Age 66)
    CFO, Treasurer & Assistant Secretary
    Compensation: $662.99k
  • Dr. Randi Isaacs M.D. (Age 68)
    Chief Medical Officer
    Compensation: $702.43k
  • Dr. Chulani Karunatilake Ph.D. (Age 64)
    Chief Technology Officer
    Compensation: $343.43k
  • Ms. Ellen A. Lubman M.B.A. (Age 48)
    Chief Business Officer


This page (NASDAQ:HOWL) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners